308. Progressive leukoencephalopathy Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 4 /  Drugs : 4 - (DrugBank : 1) / Drug target genes : 5 - Drug target pathways : 2

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Fosigotifator
   Calico Life Sciences LLC
      2023   Phase 1/Phase 2   NCT05757141   Canada;Netherlands;United States
   McGill University Health Centre/Research Institute of the McGill University Health Centre
      2025   -   NCT07300397   Canada
      2024   Early Phase 1   NCT07272525   Canada
Hematopoetic stem cell transplantation
   University of Pittsburgh
      2012   -   NCT03333200   United States
Palliative care
   University of Pittsburgh
      2012   -   NCT03333200   United States